Effectiveness of statin therapy in adults with coronary heart disease

Archives of Internal Medicine
T J WiltAnne Sales

Abstract

We conducted a meta-analysis of patients with coronary heart disease (CHD) to determine the effectiveness of statin therapy; whether effectiveness varied according to patient characteristics, outcomes, or pretreatment low-density lipoprotein cholesterol (LDL-C) levels; and the optimal LDL-C goal and the level at which to initiate statin therapy. Randomized trials or systematic reviews for secondary prevention of CHD with statin therapy published between January 1966 and December 2002 were identified through MEDLINE and the Cochrane Library. Studies were included if they randomly assigned adults with CHD to statin therapy or control, enrolled at least 100 individuals per arm, reported clinical outcomes and LDL-C levels, and were published as full studies in English. Two reviewers abstracted data using a prospectively designed protocol. Twenty-five studies enrolling 69 511 individuals were included. Participants in 19 placebo-controlled trials had a mean age of 63 years and a mean pretreatment LDL-C level of 149 mg/dL (3.85 mmol/L); 23% were women. Statin therapy reduced CHD mortality or nonfatal myocardial infarction 25% (relative risk [RR], 0.75; 95% confidence interval [CI], 0.71-0.79), all-cause mortality 16% (RR, 0.84; 95% C...Continue Reading

Citations

Feb 28, 2009·Journal of Endocrinological Investigation·K SezerE Akbay
Jan 31, 2014·American Journal of Respiratory and Critical Care Medicine·Talmadge E KingPaul W Noble
May 31, 2014·Canadian Journal of Physiology and Pharmacology·Matthew J Durand, David D Gutterman
Apr 28, 2006·Journal of General Internal Medicine·Catarina I Kiefe, Anne Sales
Jan 31, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Igor KarpLouise Pilote
Mar 5, 2009·Antimicrobial Agents and Chemotherapy·Rina P M Wong, Timothy M E Davis
Jul 15, 2009·Annals of Family Medicine·Grant M RussellMeltem Tuna
Nov 5, 2009·Journal of General Internal Medicine·Philip J SaylorMatthew R Smith
Nov 28, 2009·European Journal of Applied Physiology·Dick H J ThijssenDaniel J Green
Mar 25, 2010·BMC Public Health·Simone DahrougeElisabeth Kristjansson
Oct 20, 2010·Vascular Health and Risk Management·Joel A Lardizabal, Prakash C Deedwania
Nov 26, 2010·Current Atherosclerosis Reports·Joel A Lardizabal, Prakash C Deedwania
Aug 20, 2011·PloS One·Xuemei HuangUNKNOWN Parkinson Study Group DATATOP Investigators
Sep 14, 2011·PloS One·Peter BergmanLinda Björkhem-Bergman
Dec 19, 2013·Iranian Red Crescent Medical Journal·Seyed Kianoosh HosseiniMasoumeh Lotfi Tokaldany
Sep 21, 2010·The European Journal of General Practice·Patricia FitzpatrickLeslie Daly
Sep 30, 2009·Current Medical Research and Opinion·Leiv OseValerie Arneson
May 31, 2007·Current Medical Research and Opinion·Robert J StrakaMichael J Koren
May 17, 2011·The American Journal of Geriatric Pharmacotherapy·Ahmed Alhusban, Susan C Fagan
Jan 25, 2011·Cardiology Clinics·Joel A Lardizabal, Prakash Deedwania
Sep 21, 2010·The Journal of Thoracic and Cardiovascular Surgery·Muthiah VaduganathanPatrick M McCarthy
Sep 11, 2009·Journal of Clinical Epidemiology·Daniel Jane-witJohn Concato
Oct 7, 2008·Journal of Clinical Epidemiology·Kent R JohnsonMarissa N D Lassere
Nov 10, 2005·The Journal of Clinical Hypertension·Thomas D Giles, Gary E Sander
Oct 13, 2005·Statistics in Medicine·Peter C Austin, Muhammad M Mamdani
Jun 15, 2007·Expert Opinion on Pharmacotherapy·J Rumi JaumdallyGregory Y H Lip
Jun 16, 2012·Journal of the American College of Cardiology·David L BrownJustin Oakley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.